After validation of a subgroup of DEGs by using an additional pancreatic adenocarcinoma dataset, we found that GJB2 were upregulated and ERO1LB downregulated in malignant tissues than in normal pancreatic tissues. This evidence concerns the gene GJB2 and pancreatic adenocarcinoma.